INNOPEUTICS
Live / Registered — Registered (as of 29 Sept 2026)
What this means for you
Registered since 29 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Sept 2032: the §71 affidavit of use).
Record
- Serial number
- 79445256
- Registration number
- 8465850
- Mark type
- Design + words
- Filed
- 18 Dec 2025
- Published for opposition
- 11 Aug 2026
- Registered
- 29 Sept 2026
- Next maintenance filing
- §71 affidavit of use, due by 29 Sept 2032 (grace period to 29 Mar 2033)
- Attorney of record
- Kwang Yup Chae
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of leukemia; Pharmaceutical preparations for the treatment of cells, namely, pharmaceutical preparations for cellular therapy for the treatment of autoimmune diseases, and pharmaceutical preparations for cellular therapy for the treatment of cancer; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for treating malignant tumours; Pharmaceutical preparations for the treatment of viral and infectious diseases and for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases; Biotechnological preparations for medical purposes, namely, for the treatment of immunological disorders; Pharmaceutical compositions for the treatment of genetic, neurological, cardiovascular, and metabolic diseases; Pharmaceuticals for the treatment of neurodegenerative disease, namely, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and neuropathy pain; pharmaceutical preparations for the treatment of auto-immune diseases; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the treatment of central nervous system diseases
Owner
Prosecution history
- 29 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 11 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Aug 2026 — PUBLISHED FOR OPPOSITION
- 05 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jul 2026 — REFUSAL PROCESSED BY IB
- 29 Jun 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 29 Jun 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Jun 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Jun 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Jun 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED